Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.7756
-0.0147 (-1.86%)
At close: Aug 28, 2026, 4:00 PM EDT
0.7800
+0.0044 (0.57%)
After-hours: Aug 28, 2026, 6:27 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $82.03 million as of August 28, 2026. Its market cap has decreased by -49.92% in one year.
Market Cap
82.03M
Enterprise Value
75.67M
1-Year Change
-49.92%
Ranking
Category
Stock Price
$0.78
ChartMarket Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $82.03M, a decrease of -9.08%. That is a compound annual growth rate of -2.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 82.03M | -3.27% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lifecore Biomedical | 171.85M |
| Organigram Global | 170.22M |
| ADC Therapeutics | 145.54M |
| BGM Group | 131.20M |
| Cumberland Pharmaceuticals | 126.76M |
| Zhengye Biotechnology Holding | 81.99M |
| InterCure | 64.74M |
| Talphera | 62.29M |